{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Infection+Control&page=12", "query": { "intervention": "Infection Control", "page": 12 }, "page_size": 10 }, "pagination": { "page": 12, "page_size": 10, "total_count": 1466, "total_pages": 147, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Infection+Control&page=13&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Infection+Control&page=11&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-23T12:51:19.481Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02367313", "title": "A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Vapendavir", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Biota Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 455, "start_date": "2015-02", "completion_date": "2016-12", "has_results": false, "last_update_posted_date": "2018-06-01", "last_synced_at": "2026-10-23T12:51:19.481Z", "location_count": 33, "location_summary": "Birmingham, Alabama • Flagstaff, Arizona • Bakersfield, California + 30 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Flagstaff", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02367313" }, { "nct_id": "NCT06809868", "title": "Role of Transposable Elements in Septic Immune Aging", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Sepsis", "Sepsis and Septic Shock", "Sepsis With Multiple Organ Dysfunction (MOD)", "Sepsis With Acute Organ Dysfunction", "Sepsis, Severe", "Sepsis at Intensive Care Unit", "Sepsis, Severe Sepsis and Septic Shock", "Sepsis, Septic Shock" ], "interventions": [ { "name": "RNA and DNA Sequencing", "type": "GENETIC" } ], "intervention_types": [ "GENETIC" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 116, "start_date": "2025-02-14", "completion_date": "2028-08-14", "has_results": false, "last_update_posted_date": "2026-01-30", "last_synced_at": "2026-10-23T12:51:19.481Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06809868" }, { "nct_id": "NCT02267382", "title": "A Study to Evaluate Oral VT-1161 in the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Recurrent Vulvovaginal Candidiasis" ], "interventions": [ { "name": "VT-1161", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Viamet", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "FEMALE", "summary": "18 Years to 65 Years · Female only" }, "enrollment_count": 254, "start_date": "2015-02-10", "completion_date": "2016-11-09", "has_results": true, "last_update_posted_date": "2019-10-15", "last_synced_at": "2026-10-23T12:51:19.481Z", "location_count": 32, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Jonesboro, Arkansas + 27 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02267382" }, { "nct_id": "NCT04180358", "title": "Capacity Builders Inc. Navajo Youth Builders Personal Responsibility Education Innovation Strategies Project", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Sexual Abstinence", "Responsible Sex" ], "interventions": [ { "name": "Native STAND", "type": "BEHAVIORAL" }, { "name": "Regular Health/Physical Education Curriculum", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Capacity Builders Inc.", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "14 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "14 Years to 18 Years" }, "enrollment_count": 834, "start_date": "2017-10-24", "completion_date": "2021-09-29", "has_results": false, "last_update_posted_date": "2019-11-27", "last_synced_at": "2026-10-23T12:51:19.481Z", "location_count": 1, "location_summary": "Farmington, New Mexico", "locations": [ { "city": "Farmington", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT04180358" }, { "nct_id": "NCT00646425", "title": "The Safety and Efficacy of Basiliximab as Maintenance Therapy in Subjects With Stable, Noninfectious Uveitis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Non-infectious Uveitis" ], "interventions": [ { "name": "Basiliximab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cerimon Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "12 Years to 80 Years" }, "enrollment_count": 5, "start_date": "2008-05", "completion_date": "2008-11", "has_results": false, "last_update_posted_date": "2010-08-19", "last_synced_at": "2026-10-23T12:51:19.481Z", "location_count": 6, "location_summary": "Cambridge, Massachusetts • Kansas City, Missouri • New York, New York + 3 more", "locations": [ { "city": "Cambridge", "state": "Massachusetts" }, { "city": "Kansas City", "state": "Missouri" }, { "city": "New York", "state": "New York" }, { "city": "Belmont", "state": "North Carolina" }, { "city": "Galveston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00646425" }, { "nct_id": "NCT02254421", "title": "Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus (RSV) Infection of the Lower Respiratory Tract", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Respiratory Syncytial Virus Infection" ], "interventions": [ { "name": "Presatovir", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 60, "start_date": "2015-01-31", "completion_date": "2017-04-17", "has_results": true, "last_update_posted_date": "2018-09-24", "last_synced_at": "2026-10-23T12:51:19.481Z", "location_count": 11, "location_summary": "Duarte, California • Chicago, Illinois • Baltimore, Maryland + 8 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT02254421" }, { "nct_id": "NCT04999592", "title": "Ceftriaxone to PRevent pneumOnia and inflammatTion aftEr Cardiac arresT (PROTECT)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Out-Of-Hospital Cardiac Arrest", "Pneumonia" ], "interventions": [ { "name": "Standard of care without prophylaxis", "type": "DRUG" }, { "name": "Antibiotic prophylaxis", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "David J. Gagnon", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 53, "start_date": "2021-08-20", "completion_date": "2024-11-01", "has_results": true, "last_update_posted_date": "2025-04-17", "last_synced_at": "2026-10-23T12:51:19.481Z", "location_count": 1, "location_summary": "Portland, Maine", "locations": [ { "city": "Portland", "state": "Maine" } ], "official_url": "https://clinicaltrials.gov/study/NCT04999592" }, { "nct_id": "NCT00274404", "title": "Controlled Trial of Valacyclovir in Infectious Mononucleosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Infectious Mononucleosis" ], "interventions": [ { "name": "valacyclovir", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2004-02", "completion_date": "2005-09", "has_results": false, "last_update_posted_date": "2011-10-27", "last_synced_at": "2026-10-23T12:51:19.481Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00274404" }, { "nct_id": "NCT00002104", "title": "Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIV", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Mycobacterium Avium-Intracellulare Infection", "HIV Infections", "Tuberculosis, Mycobacterium Infection" ], "interventions": [ { "name": "Thalidomide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Aaron Diamond AIDS Research Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": null, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2005-06-24", "last_synced_at": "2026-10-23T12:51:19.481Z", "location_count": 2, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00002104" }, { "nct_id": "NCT06805487", "title": "Evaluation of the Protective Efficacy of TV003 or Previous Zika Infection Against Infection With ZIKV-SJRP Challenge Compared to DENV and ZIKV-naïve Controls Against Infection With ZIKV-SJRP Challenge", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Zika Virus" ], "interventions": [ { "name": "TetraVax-DV-TV003 (TV003)", "type": "BIOLOGICAL" }, { "name": "Plasmalyte", "type": "BIOLOGICAL" }, { "name": "Challenge virus ZIKV-SJRP/2016-184", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "18 Years to 40 Years" }, "enrollment_count": 27, "start_date": "2024-09-24", "completion_date": "2025-09-15", "has_results": false, "last_update_posted_date": "2026-03-09", "last_synced_at": "2026-10-23T12:51:19.481Z", "location_count": 2, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT06805487" } ] }